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ABSTRACT We present a method to probe intra- and interchain activities within dimeric nonribosomal peptide synthetases.
Utilizing domain inactivation and analytical mass mutants in conjunction with rapid-quench, mass spectrometry, and a proba-
bilistic kinetic model, we have elucidated the pre-steady-state intra- and interchain rates and the corresponding ﬂux of the
acylation of L-Thr onto VibF. Although the intra rate is signiﬁcantly faster than the inter rate, the data are most consistent with an
even ﬂux of covalent substrate loading where neither pathway dominates. These pre-steady-state results conﬁrm previous
steady-state in vitro mutant complementation studies of VibF. Extension of this methodology to other dimeric nonribosomal
peptide synthetases, and to the related fatty acid and polyketide synthases, will further our biophysical understanding of their
acyl-intermediate-processing pathways.
INTRODUCTION
Many important natural products are biosynthesized by
nonribosomal peptide synthetases (NRPSs), fatty acid syn-
thases (FASs), and polyketide synthases (PKSs), and much
effort has been placed on understanding the mechanisms of
such functionally complex systems. Despite the diversity of
their products, the overall macromolecular structure and
organization of these enzymes are very similar. They consist
of individual or multiple modules comprised of several
domains, each of which is responsible for one or more of the
catalytic activities necessary for the incorporation and
tailoring of an amino acid (NRPS) or acyl-CoA (PKS/
FAS) monomer into the elongating cascade of acyl-S-
enzyme intermediates (1–4). Although FASs are unimodular
and iterative in nature (5), NRPSs and type I PKSs contain
multiple modules, usually arranged colinearly, that form an
‘‘assembly line’’ to synthesize their ﬁnal product (6).
Characterization of the quaternary structure of NRPSs,
FASs, and PKSs is not only important for understanding how
modules and domains interact, but is also of interest because
higher-order oligomeric structural arrangements allow for
alternate paths of elongation, as the cascade of intermediates
can ﬂow in cis (intrachain) or trans (interchain) along the
several active sites of the enzyme. Although solution/crystal
structures and homology models have been determined for
individual domains (7–14) and the structures of mammalian
and fungal FAS have recently been elucidated at ;5 A˚
resolution (15,16), high-resolution crystal structures have yet
to be reported for an entire NRPS, FAS, or PKS module. It
has been shown that FAS (17–21) and deoxyerythronolide B
synthase PKS subunits (22–24) are obligate homodimers and
can operate through both intra- and interchain elongation
cycles. Topology has been additionally investigated by an in
vitro mutant complementation strategy where catalytically
active heterodimers can be formed from two differentially
modiﬁed inactive homodimers (23–27). Various models
have been proposed to describe the organization of the olig-
omeric state of these megasynthases, including head-to-tail
dimers and head-to-head interwound helical dimers (5,22).
Smith and co-workers recently reported the engineering of
an active animal FAS dimer with only one competent subunit
(28). This information, in combination with reexamination of
the speciﬁcity of cross-linking (14) and recent cryoelectron
microscopy analysis (29–32), has resulted in the proposal of
a revised head-to-head coiled arrangement for FAS (14,32).
There remains considerable uncertainty over the higher-
order structure of NRPSs in general (33,34), but it has been
shown that the VibF subunit of vibriobactin synthetase is
dimeric (33). Vibriobactin synthetase (Fig. 1) is a four-
subunit NRPS system responsible for synthesizing an iron-
chelating catechol siderophore that contributes to a system of
iron acquisition essential for virulence of Vibrio cholerae
during vertebrate infection (35). The ordering of domains
within VibF (Cy1-Cy2-A-C1-PCP-C2) deviates from the
canonical NRPS repeat (C-A-PCP) and contains a conden-
sation domain (C1) in a location that is usually reserved for
modifying domains. After biochemical reconstitution of the
full assembly line for vibriobactin production allowed for the
assignment of function to the six domains of VibF, it was
determined that C1 is catalytically inactive (36). Although
somewhat common in PKSs (37–39), NRPSs rarely contain
catalytically inactive domains (40–42). Deletion of the C1
domain results in the formation of two subfragments (Cy1-
Cy2-A and PCP-C2) of VibF, which together can fully
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reconstitute vibriobactin production but no longer form a
higher-order structure. It was shown that although the C1
domain plays no catalytic role, it is primarily responsible for
the dimerization of VibF and may properly position neigh-
boring domains to enhance catalytic activity (42). Previous in
vitro mutant complementation studies of VibF revealed that
the Cy1, Cy2, A, and C2 domains can perform their activities
in both intra- and interchain fashions, and that the Cy1, Cy2,
and A domains show no clear preference for intra- or in-
terchain activity when overall vibriobactin production rates are
monitored (33). However, the steady-state detection of any
such kinetic preferences via in vitro mutant complementation
could be suppressed by a subsequent slow step, and the rate-
limiting step performed by VibF has not been identiﬁed.
Here we introduce a mass spectrometric approach coupled
with a probabilistic kinetic model to probe the intra- and
interchain rates and corresponding ﬂux within dimeric
NRPS, FAS, and PKS enzyme complexes, demonstrating
proof of principle through application of this methodology to
the dimeric NRPS module VibF. Using high-resolution mass
spectrometry (MS), we assayed the acylation of the peptidyl
carrier protein (PCP) with L-Thr, catalyzed by the adenyl-
ation (A) domain. Distinct enzymatic activities were mon-
itored by mixing two constructs, an analytical mass mutant
in the PCP domain (hereafter denoted by PCPa) and a cata-
lytically inactive A domain mutant (33) (hereafter denoted
by A*), to yield homo- and heterodimers of PCPa and A*
(Fig. 2). The analytical mass mutation to the PCP domain
was designed to not affect function, at the same time
allowing intermediates tethered to a PCPa domain to be
distinguishable by MS from those tethered to a wild-type
PCP. Such mixtures of PCPa and A* interrogated in the pre-
steady-state revealed the rates of VibF intra- and interchain
acylation and to what extent L-Thr is transferred through
each pathway. Features of high-resolution MS, such as high
mass accuracy (typically ,1 Da) and the ability to obtain
semiquantitative regiospeciﬁc information, facilitate its use
as a largely unbiased measurement tool to unambiguously
interrogate the covalent catalysis executed by thiotemplate
enzymes in the biosynthesis of many therapeutically inter-
esting natural products.
MATERIALS AND METHODS
Design and puriﬁcation of VibF mutants
The gene for the analytical PCPa mutant was constructed via the method
of splicing by overlap extension (SOE) (43) using pVibF (35) plasmid as
the template. The accession number for the complete VibF sequence is
AF287255. In the ﬁrst round of PCR ampliﬁcation, the 59 fragment of the
mutant was ampliﬁed using the primers 59-GGTGACTTGGTTAGTGGA-
TCCTCCAGTGCATC-39 and 59-CAAGCGACCAATGACTGTCGTTG-
CGATCAGGG-39 and the 39 fragment of the mutant was ampliﬁed using the
FIGURE 1 Overview of vibriobactin biosynthe-
sis. Vibriobactin is synthesized from two molecules
of L-Thr, three molecules of 2,3 dihydroxyben-
zoate, and one molecule of norspermidine by a
four-component NRPS comprising VibB, VibE,
VibF, and VibH.
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primers 59-CCCTGATCGCAACGACAGTCATTGGTCGCTTG-39 and
59-GTTCATCACGTACGAAATTGAGTC-39 (bold print indicates muta-
tions). After PCR puriﬁcation the two fragments were mixed together and
further ampliﬁed using the forward primer from the 59 fragment and the
reverse primer from the 39 fragment. All PCR ampliﬁcations were performed
for 30 cycles with 1 min of denaturation at 94C, 1 min of annealing at 52C,
and either 1.5 min (ﬁrst-round SOE) or 2.25 min (second-round SOE)
extension at 72C. The ﬁnal product was digested with BsiWI/BamHI and
ligated into a similarly digested pC1PCPC2 (42) plasmid. This construct was
then digested with BamHI/XhoI and the fragment carrying the analytical
PCP mutant was ligated into a similarly digested pVibF (35) plasmid. DNA
sequencing to verify PCR ﬁdelity was performed on double-stranded DNA
by the Molecular Biology Core Facilities of the Dana Farber Cancer Institute
(Boston, MA). Constructs for wild-type VibF (35) and the A domain mutant
A* of VibF (33) were obtained as previously described.
The described expression plasmids were transformed into Escherichia
coli BL21 (DE3) competent cells and grown at 15C in Luria-Bertani media
supplemented with 5 mM MgCl2 and 40 mg/mL kanamycin to an OD600 of
0.5–0.8 when the culture was induced with 100 mM IPTG and then grown
for an additional 12–36 h continuing at 15C. The cells were harvested by
centrifugation at 4000 3 g for 16 min and stored as pellets at 80C until
further use. Cell pellets from 24 L of culture were thawed and resuspended in
120 mL of lysis buffer (25 mM Tris, pH 8.0, 500 mM NaCl) and then lysed
with two passes on an Emulsiﬂex-C5 cell disruptor (Avestin, Ottawa,
Canada). The lysate was cleared by ultracentrifugation at 95000 3 g for
35 min and then transferred to 3 mL of Ni-NTA Superﬂow resin (Qiagen,
Valencia, CA) for incubation at 4C for 1.5 h. The resin was then transferred
to a column and the protein was eluted with an imidazole gradient using
steps of 35 mL of 0 and 5 mM imidazole, 25 mL of 25-mM imidazole, and
then 15 mL of 50-, 75-, 100-, 125-, 150-, and 200-mM imidazole mixed into
lysis buffer. After running an SDS-PAGE gel to verify which fractions
contained the protein, the 100- through 200-mM imidazole fractions were
dialyzed overnight against 20 mM Tris, pH 8.0, 50 mMNaCl, 2 mMMgCl2,
1 mM DTT, and 10% glycerol. The dialyzed protein was then concentrated
to 3 mL, ﬂash frozen in liquid nitrogen, and stored at 80C.
Secondary aminoacylation assay
VibB and VibF were initially phosphopantetheinylated with Sfp (44) for 1 h
at 30C in reactions containing 150 mM Tris, pH 7.5, 10 mMMgCl2, 1 mM
tris(2-carboxy-ethyl)phosphine hydrochloride (TCEP), 100 mM CoA, 200
mM 2,3-dihydroxybenzoic acid (DHB), 5 mM VibB, 300 nM Sfp, and 250
nMVibF. Secondary aminoacylation was then initiated by the addition of 10
mMATP, 60 mM Tris, pH 7.5, 1 mMVibE, 50 mMDHP-mOx-NSPD-DHB
(prepared as previously described (36)), and 10 mM L-Thr. Reactions were
quenched at given time points by addition of nine volumes ice cold methanol
and the protein precipitate was removed by centrifugation at 11,6003 g for
FIGURE 2 Scheme for A*PCP 1
PCPa mixing experiment. Homodimers
of the A* mutant are unable to undergo
catalysis, and A domains from homo-
dimers of the PCPa mutant perform both
intra- and interchain acylation. Mixing
of the two species to form heterodimers
results in the A*PCP undergoing only
interchain acylation and the PCPa un-
dergoing only intrachain acylation. The
two PCP fragments can be resolved by
MS after trypsinolysis due to the analy-
tical mass mutation introduced into the
PCPa fragment, which increases its mass
by 370.22 Da.
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15 min at 4C. The resultant supernatant was dried under vacuum and
resuspended in 80 mL of 15% acetonitrile. Samples were injected onto a C18
Vydac (Hesperia, CA) smallpore column on a Beckman (Fullerton, CA)
System Gold and products were eluted at 1 mL/min in a gradient from 10%
to 100% acetonitrile in 0.1% TFA over 23 min. Product elution was
monitored at 254 nm. Peak integrations were converted to nanomoles of
vibriobactin as described previously (35).
Incubations for L-Thr loading of VibF
Before substrate loading, the PCP domain of VibF (4 mM) was ﬁrst
phosphopantetheinylated in 50 mM Tris, pH 7.0, 5 mM MgCl2, 5 mM TCEP,
with 500 nMSfp and 65mMCoA-SH for 1–4 h at 30C in 90-mL reactions. For
the A* and PCPa control experiments, 10 mM L-Thr and 10 mM ATP were
added to A* or PCPa following Sfp treatment in a 100-mL ﬁnal volume,
incubated at 30C for 15 min, and digested using the protocol described below.
The characteristic time for VibF dimer exchange ranges from 15 min to
1 h (33). For the heterodimer formation and in trans activity assays, A* and
PCPa were mixed 1:1 during phosphopantetheinylation (4 h) to allow dimer
reequilibration to homodimers and heterodimers. The dimer mixture was
then incubated with 10 mM L-Thr and 10 mM ATP for 15 min at 30C and
immediately digested using the protocol described below. For the PCPa and
wild-type VibF time courses, holo-PCPa or holo-VibF was incubated with
10 mML-Thr and 10 mMATP and quenched in 1–5% formic acid at various
time points using a KinTek (Austin, TX) quench-ﬂow instrument. For the
extreme A*/PCPa ratio mixing experiments, mixtures of A* and PCPa were
mixed in 1:8 or 8:1 ratios during the phosphopantetheinylation reaction
(1 h). The dimer mixture was then incubated with 10 mM L-Thr and 10 mM
ATP and quenched in 1–5% formic acid at various time points using a
KinTek quench-ﬂow instrument. For all samples quenched by the KinTek
quench ﬂow, the pH was readjusted to;8 before immediate digestion using
the protocol described below. Neither enzyme activity nor signiﬁcant
hydrolysis was observed during the digestion process (data not shown).
Digestion conditions
Proteolysis was performed by the addition of N-tosyl-L-phenylalanine-
chloromethyl ketone-treated trypsin (Promega, Madison, WI) to 0.4 nmol of
the target protein at protease/substrate ratios ranging from 1:5 to 1:10 w/w in
50 mMNH4HCO3, pH 7.8, and incubated at 30C for 5 min. Reactions were
quenched by the addition of a minimal volume of 10% formic acid (Acros,
Morris Plains, NJ) and applied to a wide-pore Jupiter C4 reverse-phase
column (Phenomenex, Torrance, CA) with a linear gradient from 10% to
90% MeCN (0.1% TFA) for fractionation. Samples were lyophilized,
resuspended in 0.1% triﬂuoroacetic acid (TFA), desalted via C18-ZipTip
(Millipore, Billerica, MA), and eluted in electrospray ionization (ESI) buffer
(49% H2O, 49% MeOH, 2% formic acid) for MS analysis.
ESI/Q-FT and Q-TOF mass spectrometry
ESI was used with a custom quadrupole Fourier-transform (FT) mass
spectrometer operating at 8.5 tesla (45) and a micromass quadrupole time-
of-ﬂight (Q-TOF) Ultima instrument (Waters, Milford, MA). For FTMS, the
ions were directed through a heated metal capillary, skimmer, quadrupole,
and multiple ion guides into the ion cell (;109 Torr) of the FTMS. Scans
were acquired at a rate of 1 s1 and data were stored with a MIDAS data-
station (46) as 512 K data sets. Spectra were calibrated externally using
bovine ubiquitin (Mr ¼ 8559.62 Da) and theoretical isotopic distributions
were generated using Isopro v3.0 and ﬁt to experimental data by least
squares to assign the most abundant peak. For Q-Tof analysis, samples were
introduced through loop injection, the quadrupole operated as an ion guide
in MS mode, and a reﬂectron TOF analyzer placed orthogonally to the
quadrupole served as a mass resolving device. The instrument was con-
trolled using MassLynx v4.0 software.
Reported masses and intermediate quantiﬁcation
High-resolution mass spectrometry of large molecules results in isotopic
distributions within the mass spectra, explanations of which have been
described previously (47,48). Brieﬂy, all molecular weights in this manu-
script are reported as monoisotopic values, which refer to the molecular ion
peak composed of the most abundant isotopes of the elements including
the mass defect (i.e., C ¼ 12.000000, N ¼ 14.00307, etc.). Assignment
of isotopic distributions to the corresponding enzyme intermediates (as
displayed in Fig. 4) involved correlating the experimental monoisotopic
molecular weights to the theoretical monoisotopic molecular weights for
the enzyme intermediates, with a maximum error tolerance of 15 ppm. Two
effects disperse MS signals of differentially modiﬁed forms of carrier
peptides: 1), fractionation of chemically distinct species during chromatog-
raphy; and 2), multiple charge states observed in ESI-MS. To account for
this dispersion, high-performance liquid chromatography (HPLC) fractions
(typically two to three) containing different forms of the same carrier peptide
are physically mixed before ESI/FTMS analysis and abundance/area
information from every charge state observed of a particular species in the
broadband spectrum is considered in the determination of relative ratios. The
data displayed in Fig. 4 indicate the mass-shifting region of one particular
charge state, whereas the relative ratio information reported for a particular
experiment has accounted for every charge state present in the mass spec-
trum. A more detailed explanation and further evaluation of this quantiﬁ-
cation process has been discussed previously (49,50).
Pre-steady-state kinetic equations and data ﬁtting
Homodimeric VibF contains two A domains, one per VibF chain. Each A
domain has the capacity to load L-Thr onto either holo-PCP domain, in an
intra- or interchain fashion (33). The probability that a given PCP domain is
loaded in an intra- or interchain manner is given by ð1 PinterÞ and Pinter,
respectively. The associated rates of loading are given by kintra and kinter. In
both the PCPa and wild-type VibF homodimer pre-steady-state A domain
experiments, it is observed that the fractions of L-Thr loaded PCPa and PCP
do not approach 100%, but rather saturate around 50% (Fig. 5, A and B). One
explanation for this is that subsets of PCPa and PCP domains are
catalytically incompetent for L-Thr loading. The ratio of competent to
incompetent PCPa domains is given by d[PCPa,competent]¼ [PCPa,incompetent].
The proportion of competent PCPa is then given by [PCPa,competent]/
[PCPa,total] ¼ 1/(1 1 d). Utilizing the same parameter d, we have the
analogous relations for the PCP domains, namely d[PCPcompetent] ¼
[PCPincompetent] and [PCPcompetent]/[PCPtotal] ¼ 1/(1 1 d).
In the A*PCP1 PCPa mixing experiments, the ratio of A*PCP to PCPa is
given by a[A*PCP] ¼ [PCPa]. Previous biochemical and biophysical
experiments have shown that the C1 domain is largely responsible for the
dimerization of VibF, and that neither the deletion of the PCP and C2
domains, nor catalytically inactivating point mutations made to the Cy2,
PCP, or C2 domains signiﬁcantly affects the monomer-dimer equilibrium
of VibF (33,42). It is assumed, therefore, that the homo- and hetero-
dissociation constants for A*PCP and PCPa are equivalent. It can then be
shown that the proportions of PCP and PCPa domains in a heterodimer
context are given by [A*PCPPCPa]/[PCPtotal] ¼ a/(1 1 a) and [A*PCP
PCPa]/[PCPa,total] ¼ 1/(1 1 a). Note that in the instance of A*PCPPCPa
heterodimer, there is only one functional copy of the A domain (on the PCPa
chain), and therefore the PCPandPCPa domains are forced to utilize inter- and
intrachain A domain pathways, respectively.
For the PCPa and wild-type VibF homodimer experiments, the temporal











holoPCPðaÞ is the residual fraction of holo-PCP(a) as a function of
time, t, after the A domain loading reaction has been initiated with L-Thr.
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For the A*PCP 1 PCPa mixing experiments, the fractions of holo-PCPa





























holoPCP are the residual fractions of holo-PCPa
and holo-PCP, respectively. Note that in the expressions above, we must
account for the two subpopulations of PCP(a): one is in the context of the
heterodimer, and the other is in the context of the homodimer.
The system of equations for the pre-steady-state VibF A domain kinetics
model presented above contains four free parameters, namely d, Pinter, kinter,
and kintra. These parameters were ﬁt to the observed experimental data by the
numerical optimization method of steepest descent, minimizing the sum
of the residual errors squared. The R value given in Table 1 is Pearson’s
correlation coefﬁcient. Gaussian noise comparable to that characteristic of
the experimental technique (m ¼ 0%, s ¼ 5%) was applied to the observed
data, and pseudo-best-ﬁt parameters were derived by reﬁtting to the
perturbed data. This procedure was repeated (N ¼ 10,000) times to generate
a distribution of pseudo-best-ﬁt parameters, and these were then utilized to
estimate the error in the best-ﬁt parameters, providing the mean, standard
deviation, and 95% conﬁdence intervals for each parameter derived directly
from the pseudo-best-ﬁt distributions. The data ﬁtting and best-ﬁt parameter
error estimation programs are available from the authors upon request.
To estimate the average fraction of secondary aminoacylation cycle
time attributable to L-Thr acylation, we divide the average acylation time
by the total cycle time, which is simply the inverse of the experimentally
determined secondary aminoacylation rate. The average time required to
perform L-Thr acylation, in terms of the best-ﬁt kinetic parameters, is given
by (1  Pinter)/kintra 1 Pinter/kinter.
RESULTS
Generation and secondary aminoacylation assay
of the analytical mass mutant PCPa
To discriminate intra- from interchain acylation of the VibF
PCP domain following L-Thr adenylation, we exploit the
fact that in heterodimers of wild-type and inactive A domain
mutants of VibF, the PCP domain in cis to the active A
domain can only undergo intrachain catalysis and the PCP
domain in trans to the active A domain can only undergo
interchain catalysis (Fig. 2). A consequence of proteolytic
processing that is requisite before MS identiﬁcation of
intermediates bound to the phosphopantetheinylated serine
active site of the PCP domain (see Experimental Procedures)
is the loss of topological information linking a given PCP
domain in cis with an active or mutated A domain. To pre-
serve this information after proteolysis, an analytical mass
mutant of VibF was generated to differentiate the PCP
domains that lie in cis to an active A domain.
Five residues downstream from the phosphopantetheiny-
lated Ser1891 in VibF lies Arg1896, which is closely followed
byArg1900. ReplacingArg1896with Thr (R1896T), amutation
predicted to be well tolerated on the basis of sequence
alignment to other known PCP domains (data not shown),
results in a PCPa mutant that after trypsinolysis yields a
peptide fragment containing Ser1891, spanning fromSer1871 to
Arg1900 (3126.50 Da) that is 370.22 Da larger than the anal-
ogous fragment derived from the wild-type PCP domain,
spanning from Ser1871 to Arg1896 (2756.28 Da) (Fig. 2). Even
after heterodimers of the VibF analytical mass mutant PCPa
and the inactive A domain mutant A* (containing a wild-type
PCP domain) have been digested with trypsin, it remains
discernible which PCP fragments underwent interchain
catalysis, namely the smaller wild-type proteolytic fragments
derived from A*, and which underwent intrachain catalysis,
namely the larger analytical mutant proteolytic fragments
derived from PCPa (schematized in Fig. 2).
The analytical mutant was generated using standard PCR
and molecular biology techniques described in Experimental
Procedures. All VibF constructs, wild-type, A*, and PCPa,
were expressed in E. coli as C-terminal His-tagged proteins
and puriﬁed by nickel afﬁnity chromatography. All proteins
were obtained in comparable yield (1–2 mg/L) and purity
(95%), and migration on SDS-12% PAGE was consistent
with the calculated VibF mass of 271 kDa (Supplementary
Material, Fig. S1).
Once the analytical mass mutant was generated, it was
tested against wild-type VibF enzyme for its ability to
catalyze secondary aminoacylation. In this assay, VibF must
generate (dihydroxyphenyl)methyloxazolinyl-S-VibF (DHP-
mOx-S-VibF) before the transfer of this species to the N5
of the DHP-mOx-norspermidine-dihydroxybenzoyl (DHP-
mOx-NSPD-DHB) intermediate substrate to form the ﬁnal
vibriobactin product (Fig. 1) (36). Using initial rates of
vibriobactin production, it was determined that the second-
ary aminoacylation kcat for the analytical mass mutant (8.26
0.3 min1) was ;3.6 times slower than that for wild-type
VibF (29 6 0.7 min1). Although the analytical mutant was
designed to be minimally perturbative to the function of VibF,
it does appear to modestly alter the kinetics of vibriobactin
production. However, this ﬁnding does not affect the conclu-
sions of this study, because all subsequent interrogation of
intra versus inter catalytic rates was focused on the A domain
and its initial loading of L-Thr onto VibF. Vibriobactin
production, as assayed by secondary aminoacylation, requires
TABLE 1 Best-ﬁt parameters from numerical modeling of VibF
adenylation activity in the pre-steady-state
Pseudo-best-ﬁt parameter distribution (N¼ 10,000)
Free parameter Best ﬁt Mean 6 SD 95% Conﬁdence interval
d 1.0 1.0 6 0.1 0.8–1.3
Pinter (%) 52 51 6 11 32–68
kinter (s
1) 3.0 3.3 6 0.6 2.4–4.4
kintra (s
1) 44 41 6 9 17–51
R 0.90
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a subsequent sequence of catalytic activities, and it is prob-
able that the analytical mass mutation does not affect A




Exhaustive trypsin digestion of apo-A* yielded a 2756.31-
Da peptide (Fig. 3 A) in HPLC fraction 24, which matched
within 15 ppm to the PCP active site containing peptide
S1871–R1896 (Mtheoretical ¼ 2756.28 Da). Correlation of sub-
sequent tandem MS (MS/MS) fragmentation data (Fig. 3 B),
produced via collisionally activated dissociation, to the
peptide primary sequence validated the identity of the active
site containing peptide (Fig. 3 C). Analogously, a trypsin
digest of the apo-PCPa yielded a 3126.52 Da peptide in
HPLC fraction 25, which matched within 15 ppm to S1871–
R1900 (Mtheoretical ¼ 3126.50 Da). Subsequent MS/MS also
validated the identity of this active site containing peptide
(data not shown). Examination of every individual HPLC
fraction yielded no detectable incompletely digested active
site containing peptides.
Adenylation mutant A* and analytical mass
mutant PCPa control experiments
Incubation of the A* and PCPa constructs with Sfp (44) and
coenzyme A resulted in nearly complete phosphopantethei-
nylation of their respective PCP active sites to the holo- form
(1340 Da), as seen in Fig. 4, A and C, respectively, with no
trace of apo- enzyme detectable. Subsequent incubation of
the holo-A* construct with the natural A domain substrate
L-Thr yielded no detectable loading onto the PCP active site
(Fig. 4 B), as expected since the adenylation activity has been
abrogated with the D1092A mutation (33). However,
incubation of holo-PCPa with L-Thr resulted in a mass shift
of 1101 Da, corresponding to the holo- form of the protein
that had become self-loaded with L-Thr (Fig. 4 D).
Validation of heterodimer formation
and interchain L-Thr acylation
Although it has been previously shown that FAS and PKS
dimers may be dissociated and reassociated by altering salt
concentrations, temperature, or utilization of anion-exchange
chromatography (24,51), VibF dimers spontaneously sepa-
rate into monomers and reassociate under enzymatic assay
conditions (33). Incubation of a preequilibrated 1:1 mixture
of holo-A* and holo-PCPa with L-Thr for 15 min resulted in
L-Thr loading of the PCP domain of A* (Fig. 4 E), con-
ﬁrming both formation of heterodimeric species under the
assay conditions and the interchain transfer of L-Thr across
the dimer, as was shown previously by in vitro mutant com-
plementation assays (33). This key result validates this ex-
perimental approach, as is schematized in Fig. 2.
Pre-steady-state L-Thr acylation time courses
and data ﬁtting
To ensure that A domain activation and loading of L-Thr
onto the VibF PCP domain was unaffected by the analytical
mass mutation PCPa, pre-steady-state loading assays were
performed for both wild-type and PCPa VibF. In these
assays, the PCPa mass mutant performed comparably to
wild-type VibF (Fig. 5, A and B), indicating that the
reduction in kcat observed for overall vibriobactin production
in the analytical mutant must be a consequence of a subse-
quent processing step. Then, pre-steady-state loading assays
were performed on mixtures of homodimers and hetero-
dimers (Fig. 5, C and D). To minimize the background signal
from homodimers (A*A* and PCPaPCPa) present in
FIGURE 3 Identiﬁcation of the proteolytic fragment
containing the active site serine of VibF-PCP. (A) Fourier-
transform mass spectrum (25 scans) of fraction 24 of a
tryptic digest of apo-A*; the most abundant species observed
corresponds to the 31 charge state of the proteolytic frag-
ment Ser1871–Arg1896 (experimental Mr ¼ 2756.31 Da),
which contains the VibF-PCP active site serine (Ser1891).
(B) Subsequent MS/MS fragmentation and veriﬁcation of
the 2.7 kDa species assignment observed in A after signal
enhancement through selected ion accumulation using the
quadrupole Fourier-transform mass spectrometer; fragment
ions are described by which terminus they contain (i.e., b
ions contain the N-terminus and y ions the C terminus), and
the y axis has been expanded by a factor of 2.5 to aptly
visualize the fragment ions. Fragment ions labeled range in
charge state from 11 to 31. (C) Fragment ion map cor-
relating the ions observed in B to the sequence of the PCP
carrier peptide (Ser1871–Arg1896) generated from trypsinol-
ysis of apo-A*. Asterisk indicates active-site Ser1891.
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solution, mixtures of A* and PCPa were combined in 1:8 and
8:1 ratios for the formation of heterodimers (A*PCPa). The
idea here is to use relatively trace amounts of A* or PCPa, so
that the background is minimized while still providing
enough A*PCPa signal. At an 8:1 ratio of A*/PCPa, 8/9 of
PCPa is in the context of heterodimer, which means that only
1/9 of PCPa is homodimer background. The ratio selected
was optimized for detection with this MS-based assay and
could not be increased beyond 8:1 because then the total
amount of PCPa becomes too small to detect. Given the small
size of the PCP-containing peptide, the resolution of
;10,000 from a Q-TOF instrument was sufﬁcient for the
majority of kinetic time points acquired here.
Given the results from the pre-steady-state experiments, we
developed a minimal mechanistic model for VibF L-Thr
acylation that was consistent with the data. The model is
shown in Fig. 6, and the details of its mathematical imple-
mentation are described in Experimental Procedures. The
essence of the model is that there are probabilities for a given
PCP domain to be loaded in an intrachain fashion ð1 PinterÞ
FIGURE 4 A*, PCPa, and heterodimer formation con-
trol experiments. The mass shifting regions for the 31 ions
of the A*PCP domain for the (A) holo experiment and (B)
L-Thr loading experiment (1025–1075 m/z), and for the
31 ions of the PCPa domain for the (C) holo experiment
and (D) L-Thr loading experiment (1150–1200 m/z). The
results for each experiment conﬁrmed expectations: the
A* construct was unable to load L-Thr, whereas the PCPa
construct was active in L-Thr acylation. (E) Validation of
heterodimer formation and interchain L-Thr acylation. A
1:1 mixture of A* and PCPa yielded heterodimer formation
and subsequent L-Thr acylation on the A*PCP domain, as
displayed in the mass shifting region (1025–1075 m/z) for
the 31 ions of A*PCP.
FIGURE 5 Time courses of holo-PCP(a)
loading. Homodimer experiments: (A)
PCPa, eight data points, and (B) wild-type
VibF, six data points. A*PCP 1 PCPa
mixing experiments: (C) A*PCP/PCPa ¼
1:8, 32 data points, and (D) A*PCP/PCPa¼
8:1, four data points. Observed data shown
as data points (dots, PCPa; cross-hatching,
PCP). Pre-steady-state kinetics model
shown as lines (solid line, PCPa; dashed
line, PCP). Some data points are over-
lapping (see supplemental data Table S1).
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or in an interchain fashion (Pinter), and there are acylation rates
associated with each pathway, namely kintra and kinter,
respectively. There is only one additional free parameter in
the model, d, which dictates the fraction of PCP(a) that is
unable to be loaded. The beneﬁts of this particular model are
that it contains only four free parameters, yet is sufﬁcient to
describe the L-Thr acylation ﬂux, and the characteristic intra-
and interchain loading rates. The results of ﬁtting the model’s
parameters to the data are given in Table 1. Notably, the
probability for a given PCP domain to be loaded in an
interchain fashion (Pinter) is not signiﬁcantly different from
50% (consistent with a neutral ﬂux for L-Thr loading), and the
best-ﬁt intrachain loading rate (kintra) is signiﬁcantly faster
than the interchain rate (kinter).
DISCUSSION
Despite biochemical characterization of VibF, fundamental
questions concerning rates of catalysis of individual domains
remained unresolved. Previous steady-state heterodimeric
mutant complementation experiments established that the
Cy1, Cy2, and A catalytic domains within VibF act on
tethered intermediates in both intra- and interchain fashions,
whereas C2 appears to operate predominantly in an intra-
chain manner (33). However, the actual kinetic preference
for intra- or interchain catalysis would be masked if both
occur faster than the rate-limiting step. The strategy de-
scribed herein enables the determination of pre-steady-state
intra- versus interchain rates and ﬂux preferences for non-
rate-limiting steps in a competitive context (i.e., both path-
ways are possible and in competition with each other), in
contrast with previous complementation experiments in
which only one pathway was possible.
Here, a mass spectrometric approach has been used to
monitor enzymatic activities resulting from mixtures of the
A* (catalytically inactive A domain mutant) and PCPa
(analytical mass mutant) constructs to determine the pre-
steady-state rates of VibF intra- and interchain acylation and
to what extent L-Thr is transferred through each pathway.
Essential for the MS-based approach described here, the
catalytically active analytical mass mutant construct was
introduced to distinguish the two carrier protein domains
(PCP and PCPa) involved in the dimeric complex by a mass
difference after proteolysis. Indeed, the exploration of
covalent catalysis, exploitation of high mass accuracy, and
the ability to obtain semiquantiﬁable regiospeciﬁc informa-
tion warrants futher reﬁnement and application of this strat-
egy to other such systems containing higher-order quaternary
structure. For example, the extension of this strategy to other
dimeric FAS and PKS multienzyme complexes, for which
nearly pure heterodimers can be isolated by dual-afﬁnity
chromatography of differentially tagged constructs (27),
would allow for the examination of ﬂux partitioning in a
competitive context while simultaneously simplifying the
modeling necessary (as the active homodimer background
would be absent from the experiment).
The beneﬁts of the mass spectrometric approach developed
in this work merit comparison with what more conventional
rapid-quench approaches provide. A traditional route would
be to perform the complementation assay at pre-steady-state
with a radio-labeled substrate in a rapid-quench device,
working up the reaction with hydrolysis and subsequent
quantitation of the intermediate via radioactive chromatogra-
phy (52,53). Unlike the MS approach, which utilizes an
analytical mass mutation (PCPa) to directly determine the
product attributable to each pathway, the traditional rapid-
quench approach cannot distinguish between product
fractions arising from intra- and interchain pathways. A con-
sequence is that traditional rapid-quench requires the use of
speciﬁc complementation pairs for which only one pathway is
possible (e.g., only the interchain pathway is permitted in
heterodimers of A* and PCP*). Although these prerequisite
pair selections can result in determinations of kintra and kinter,
the rates are not entirely physiologically relevant, because
they are not measured when the two pathways are in compe-
tition with each other. In contrast, theMS approach uses com-
plementation pairs for which both pathways are possible (e.g.,
in heterodimers of A* and PCPa), and thereby does not suffer
from this limitation. Another concern with the traditional
approach is that it requires normalization of the product out-
put, and thus is dependent on accurate estimates for the total
enzyme concentration, as well as for the ratio of concentra-
tions for the twomutant proteins in the complementation pair.
There is no normalization required for the MS approach,
which measures the intermediate while still attached to the
PCP peptide fragment.
When determining the secondary aminoacylation rate for
wild-type VibF, the measured kcat was found to be 29 6
FIGURE 6 Model for VibF A domain kinetics. Hypothetical placement
of A and PCP domains within homodimeric VibF (Cy1, Cy2, C1, and C2
domains removed for clarity). Subscript numbering assigns each domain
to one of the two VibF chains. Each PCP domain may be loaded by an
A domain in an intra- or interchain fashion, with associated probabilities
ð1 PinterÞ and Pinter, and rates kintra and kinter, respectively.
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0.7 min1, which is different from the previously published
rates of 41 min1 (36) and 48 min1 (33,42). These dif-
ferences are attributed to slight protocol variations in VibF
protein preparation between this work and previous studies,
as the kcat values reported here were reproducible with sepa-
rate batch preparations of VibF (data not shown). Further-
more, it was unanticipated that the analytical mass mutation
PCPa would result in a 3.6-fold reduction in the secondary
aminoacylation rate relative to wild-type VibF. Since many
PCP domains have a threonine at the position of the VibF
PCPa R1896T substitution, we speculate that it is not thre-
onine itself, but possibly threonine in the context of spatially
neighboring VibF residues, that is responsible for this reduc-
tion in aminoacylation rate. Subsequent pre-steady-state L-Thr
acylation experiments revealed that the mutation minimally
affected the A domain (Fig. 5, A and B), and therefore must
affect some subsequent catalytic step in vibriobactin forma-
tion. However, despite determining that the overall rate of
acylation is unaffected, we are unable to unambiguously
show that the analytical mass mutation does not perturb the
ﬂux across the heterodimer. It is interesting to note that this
single point mutation in a nonconserved surface-exposed
residue could cause such a noticeable effect and argues that
individual residues within the PCP domain may be important
to some, but not necessarily all, interactions with upstream
and downstream domains.
There are several features of the pre-steady state exper-
imental data that should be highlighted. L-Thr loading
saturates near 50% for both PCPa and wild-type VibF (Fig. 5,
A and B, and Supplementary Material, Table S1). Because
this observation is common to both PCPa and wild-type
VibF, the analytical mass mutation PCPa is not implicated as
the cause, but the effect could be explained by subpopula-
tions of PCP(a) (referring to PCP and/or PCPa) that are unable
to be successfully loaded (at least on the time scale of the
assay), a competition between loading and hydrolysis, sub-
populations of PCPa and wild-type VibF with inoperable A
domains, or various combinations thereof. It should be
pointed out that it is not possible with the current data to
discriminate between these hypotheses. Incorporation of hydro-
lysis and/or inoperable A domains into the model would
result in very similar estimates for Pinter and kintra:kinter, but
would tend to increase the absolute ﬁtted values of kintra
and kinter.
As can be surmised from the spread in the replicate data
points shown in Fig. 5 and listed in supplemental Table S1,
the standard measurement error of the fraction of holo-PCP(a)
is in the neighborhood of 65%, but the absolute error is
likely to be more extreme when the L-Thr-S-PCP(a) species is
not very abundant. In the 1:8 A*/PCPa mixing experiment,
loaded PCP is not observed for the ﬁrst two time points (0.10
and 0.15 s). It seems unlikely that there is no loading until
0.20 s, at which point ;30% of the PCPs are observed to be
loaded. A reasonable explanation for the ﬁrst two time points
is that there is simply not enough signal to detect the loaded
PCP species. In this particular mixing experiment, only 1/9
of the total protein is A*, and thus there is much less total
signal in the PCP channel than in the PCPa channel.
The correlation coefﬁcient between the pre-steady-state
experimental data and the model for A domain function is
modest at R ¼ 0.90. The above noted 65% standard
measurement error and the absolute measurement error due
to instances of insufﬁcient L-Thr-S-PCP(a) signal both
contribute to the data ﬁtting error. It would be possible to
improve the data ﬁtting with additional free parameters (such
as a distinct d for each preparation of PCPa, A*, and wild-
type VibF), but this would lead to concerns of over-ﬁtting the
data and would not provide any additional mechanistic
insight.
The best-ﬁt Pinter value of 52% is consistent with a neutral
L-Thr ﬂux. The 95% conﬁdence interval for Pinter between
32% and 68% is tighter than would be expected for a
uniformly random distribution, but does not provide ample
assurance that the ﬂux is not skewed moderately toward the
intra- or interchain pathways. On the other hand, the best-ﬁt
intrachain loading rate (kintra) is signiﬁcantly faster than the
interchain rate (kinter), with 95% conﬁdence that kintra is at
least 14 s1 faster than kinter, and none of the N ¼ 10,000
pseudo data-ﬁttings resulted in kinter . kintra.
Attempts to identify thioester bound intermediates on
VibF during steady state, and thus to determine the rate-
limiting step in vibriobactin production, were unsuccessful
due to two major difﬁculties. In addition to VibF and Sfp,
which are present in L-Thr acylation assays, VibB, VibE,
and VibH are required to reconstitute steady-state vibrio-
bactin production (Fig. 1). We were unable to unambigu-
ously identify intermediate-bound VibF PCP fragments after
trypsinolysis by MS due to the presence of many other
coeluting fragments of similar mass derived from VibB,
VibE, and/or VibH. Therefore, we could not identify the
intermediates as enzyme-tethered species. Additionally, the
methyl-oxazaline ring in the DHP-mOx-S-PCP intermediate
is extremely labile and readily reforms the DHB-L-Thr-S-
PCP intermediate under both acidic and basic conditions,
which would yield incorrect proportions of intermediate
partitioning. Thus, we could not cleave the intermediates off
of the enzyme and identify them as soluble species.
The best-ﬁt kinetic parameters derived from the pre-
steady-state L-Thr acylation experiments are consistent with
previous in vitro mutant complementation results for VibF.
As determined by the best-ﬁt values for the pre-steady-state
kinetics (see Experimental Procedures), L-Thr acylation
should account for ;9% of the secondary aminoacylation
cycle time. With four intermediates partitioned on VibF
during steady state, this projection implies that L-Thr acyl-
ation is not the rate-limiting step in vibriobactin formation. In
previous complementation experiments, the VibF mutant
pair with the active A domain located in cis to the active PCP
domain (i.e., utilizing intrachain A domain activity), pro-
duced vibriobactin more quickly than those pairs with the
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active A domain operating in an interchain fashion (33). This
is in agreement with the best-ﬁt kintra being signiﬁcantly
faster than kinter, given that the A domain activity is not the
rate-limiting step.
We have developed a probabilistic kinetic model coupled
with a mass spectrometric approach to probe intra- and
interchain rates and corresponding ﬂuxes of catalytic steps
performed within dimeric NRPS, FAS, and PKS enzyme
complexes, demonstrating proof of principle through the
application of the methodology to VibF, an NRPS subunit of
vibriobactin synthetase. The higher-order oligomeric struc-
tural arrangements of NRPSs, FASs, and PKSs allow for
alternate paths of product elongation, as the cascade of
intermediates can ﬂow in cis (intrachain) or trans (inter-
chain) along the enzymatic assembly line. Although previous
steady-state complementation studies have been able to
establish which catalytic steps may operate in intra- and/or
interchain fashions, this has been in the context of only one
pathway being available at a time. The approach we forward
here utilizes rapid-quench experiments coupled with a
reporter mutation and mass spectrometry to distinguish pre-
steady-state intra- versus interchain rates and ﬂux prefer-
ences for non-rate-limiting steps in a competitive context
(i.e., both pathways are possible and in competition with
each other). The analytical mass mutant concept may be
applied fruitfully to a diversity of tasks beyond NRPS, FAS,
and PKS characterization, especially when it is desirable to
distinguish peptide digest fragments originating from highly
homologous proteins. A sample application would be to
facilitate the mass spectrometric determination of protein
complex topology via cross-linking and subsequent digest,
when multiple subunits within the complex have very high
sequence identity.
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